Podcasts about Clinical research

Send us Fan MailLeslie Byatt joins Dr. Michael Koren to talk about leadership in the clinical research space. The two research professionals discuss the importance of qualified researchers in a research trial and the qualities that make for a good clinical research leader. They also talk about research as a treatment option and the benefits observed in research patients (even those in the placebo arm). They explain that the attention, care, and time with research professionals leads to better understanding and health for those who join, and that's on top of the altruistic benefits to science and health in general.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Dr. Maximillian Mair interviews Dr. Michael Jenkinson, the recipient of EANO's Best Oral Presentation Award in Clinical Research for his work on the landmark ROAM trial investigating radiation versus observation following surgical resection of atypical meningioma, published in Lancet in September 2026. Podcast Host and Interviewee:  Host: Maximillian Mair Interviewee: Michael Jenkinson   Podcast Description:    Provide this link in the notes: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01804-0/fulltext

Day three of ADHA26 in Fort Worth brings a lineup of partners doing the work alongside dental hygienists. Live from the exhibit floor, host Matt Crespin talks with Michele Lash of Dentsply Sirona about how research and the voice of the customer drive product innovation, plus the Graduate Student Research Program, now in its 19th year. GoTu's Thalía Diedrick and Cassidy Miller preview the fourth annual State of Work survey and Best in Dental, a program recognizing offices that treat temporary professionals as part of the team. Chikako Amendola and Amanda Booth of Henry Schein share the Empowering You webinar series and a growing push for medical-dental integration. And Kari Ann Kuntzelman of the American Dental Therapy Association explains where dental therapy stands across the country and how hygienists can pursue it. Four conversations, one message: the profession is moving forward.Guests: Michele Lash, RDH, BA, FADHA, CDIPC, Senior Manager, Clinical Research, Dentsply Sirona; Thalía Diedrick, Chief Marketing Officer, GoTu; Cassidy Miller, Director of Advocacy and Community, GoTu; Chikako Amendola, Executive Director, Henry Schein; Amanda Booth, Senior Marketing Specialist, Henry Schein; Kari Ann Kuntzelman, DT, Executive Director, American Dental Therapy AssociationHost: Matt Crespin, MPH, RDH, FADHA

In today's episode, we spoke with Raji Shameem, MD, and Shubham Pant, MD, MBBS. Dr Shameem is a clinical assistant professor of medicine at the Orlando College of Osteopathic Medicine, an assistant professor of Medicine at the University of Central Florida, and a physician at Orlando Health. Dr Pant is a professor in the Department of Gastrointestinal Medical Oncology and the Department of Investigational Cancer Therapeutics, as well as the director of Clinical Research at The Sheikh Zayed Center For Pancreatic Cancer Research at The University of Texas MD Anderson Cancer Center in Houston.In our exclusive interview, Drs Shameem and Pant discussed the rapidly evolving pancreatic cancer treatment paradigm, going in-depth on topics like the role of liposomal irinotecan (Onivyde), the FDA approval of daraxonrasib (Rasonque) for patients with metastatic disease, and novel treatments that are in development. The 2 experts also covered which directions they see the pancreatic cancer field moving towards in the future.

My Free tools for sites and researchers: https://coordinare.co/ Free EDC Tool: https://crc-edc-sandbox.netlify.app/ My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference! http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My CRC Academy: http://www.TheCRCacademy.com My TikTok: DanSfera

aime's LinkedIn: https://www.linkedin.com/in/jaime-valles-2a1728221/ My Free tools for sites and researchers: https://coordinare.co/ Free EDC Tool: https://crc-edc-sandbox.netlify.app/ My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profile Inato: https://go.inato.com/3VnSro6 CRIO: http://www.clinicalresearch.io My PatientACE recruitment company: https://patientace.com/ Join me at my conference! http://www.saveoursites.com Text Me: (949) 415-6256 Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorr Text "guru" to 855-942-5288 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My CRC Academy: http://www.TheCRCacademy.com My TikTok: DanSfera

2026-09-11 Hosts Craig Lipset and Jane Myles were joined by Becky Kottschade and Dr. Tufia Haddad from the Mayo Clinic to share the evolution of Clinical Trials Beyond Walls, Mayo Clinic's program for bringing digital and decentralized capabilities into clinical research.Building on Mayo's experience with remote patient monitoring, the team started by centralizing capabilities, establishing best practices, and testing new approaches in investigator-initiated trials before scaling more broadly. They discuss the importance of giving participants options for how and where they engage in a trial, what they've learned about reaching patients beyond traditional geographic boundaries, and the unexpected growth in participation from rural communities.The conversation also explores how Mayo is making these capabilities part of its standard trial approach, the challenge of measuring decentralization across studies, and what comes next—including expanding opportunities to involve local healthcare providers in research.Read their recent publication here -- https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2849940Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.

Today's menopause conversation is dominated by hormone therapy, which leaves many women who can't use it feeling left out and worried about their current and future health and well-being. This week's guests, Drs. Rebecca Dunsmoor-Su and Amy Voedisch — co-authors of Estrogen, Interrupted and hosts of the OvaryActive podcast — are here to bring some evidence-backed hope. Because no HT doesn't mean "sorry, you'll just have to suffer." Together we map out who actually shouldn't use hormone therapy versus outdated "rules" that no longer apply. The doctors break down the new NK3/NK1 "candy neuron" blockers Veozah and Lynkuet, the underrated combo drug Duavee, why vaginal estrogen is nearly contraindication-free, and how CBT, clinical hypnosis, and old-school options like gabapentin fit into the non-hormonal toolbox. Plus: bone health, DEXA scan timing, and why perimenopause — not menopause — is often the hardest stretch. Check out their book Estrogen, Interrupted and their podcast OvaryActive to learn more.Dr. Rebecca Dunsmoor-Su is a board-certified OB-GYN and Menopause Society-certified practitioner. She is the chief medical officer at Gennev, a telemedicine platform specializing in perimenopause and menopause, medical director at Seattle Clinical Research Center, and an associate clinical professor of obstetrics and gynecology at Washington State University. She holds a Masters of Clinical Epidemiology from the University of Pennsylvania.Dr. Amy Voedisch is a board certified OB-GYN and certified menopause practitioner through The Menopause Society. She is an associate clinical professor of obstetrics and gynecology at Stanford University and board-certified in Complex Family Planning. She holds a Masters of Epidemiology and Clinical Research from Stanford University.Courses and Coaching: https://livefeisty.com/courses/Sign up for our FREE Feisty 40+ newsletter: https://livefeisty.com/newsletters/feisty-40/Follow Us on Instagram:Feisty Menopause: @feistymenopauseHit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099Support our Partners:Hettas: Shop Hettas at https://alnk.to/h6KsEBr Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Previnex: Get 15% off your order with code HITPLAY at https://www.previnex.com/ Wahoo: Use the code FEISTY2026 to get a free Headwind Smart Fan (value $300) with the purchase of a Wahoo KICKR RUN at https://shorturl.at/WVhdr

Das Video zur Folge findest du hier Und hier geht's zum YouTube Kanal – gleich abonnieren und keine neue Folge mehr verpassen! ☀️ UNTERSTÜTZT DURCH DEN FOR YOU VITAMIN D3 + K2 TEST! ☀️ Gerade im Herbst und Winter – oder wenn du schon länger supplementierst – ist Vitamin D oft so ein „Ich glaub, ich bin okay"-Thema. Mein Tipp: Nicht schätzen, sondern nachmessen! Und weil Vitamin D und K2 zusammengehören, empfehle ich den For You Vitamin D3 & K2 Test. Der Test funktioniert ganz einfach zu Hause per Trockenblut: wenige Tropfen aus der Fingerkuppe, ab in den Rückumschlag – und deine Ergebnisse bekommst du übersichtlich online. Gemessen werden 25-OH-D3 und K2 (MK-7) – ideal, um deine Supplementierung sinnvoll einzuordnen und anzupassen.

Vern Davenport is a Partner at QHP Capital with 35+ years of experience building and transforming healthcare technology and services businesses. Vern is the author of Accelerating Growth, which lays out QHP's approach to scaling companies through its Management System.Allison Crumpler is the former VP of People & Culture at Catalyst Clinical Research. A professional Certified Coach with 15+ years of experience in clinical research, Allison focuses on leadership development, organizational culture, and employee engagement.Topics:Why Culture Drives PerformanceTurning Values Into BehaviorsHow to Kill Watermelon MetricsScaling Culture Across a Portfolio...and so much more.Top TakeawaysValues become culture through repetition. Operationalizing values means defining the behaviors behind them, teaching them, and reinforcing them in practice. Allison calls it the “Mr. Miyagi” approach: repeat those behaviors over and over, even when they feel obvious. That repetition is what embeds them into the organization and gives managers and employees a shared language for accountability.Measure culture with leading indicators, not just engagement surveys. Allison shares a few of the metrics Catalyst used to measure culture beyond traditional engagement and turnover data. They called them “Key Culture Indicators”: employee referrals, town hall attendance and time to hire. Put a target against each indicator, review it alongside operating KPIs, and set a more ambitious target once the current one is consistently achieved.Make the financials visible so everyone knows how they contribute. An individual contributor in a 1,000-person company can't see how they move EBITDA, so they disengage. Catalyst shared key company metrics across the organization, then helped teams understand how their own work affected sales, customer satisfaction and financial performance. Transparency turned "just doing my job" into "we win or lose together."About QHPQHP Capital is a private equity firm focused on middle-market life sciences and pharma services businesses. With $4.5B+ in AUM, QHP combines decades of sector experience with an operator-led approach to investing. Across its portfolio, the firm implements its proprietary Management System to build stronger leadership teams, operating infrastructure and commercial capabilities and support long-term, independent growth.About Catalyst Clinical ResearchCatalyst Clinical Research is a technology-enabled clinical research organization (CRO) specializing in oncology and providing clinical development services to biotechnology and pharmaceutical companies globally.Investors & Operators is brought to you by 51 Labs51 Labs is a marketing agency for the lower middle market. We offer full-service digital marketing for PE, portfolio companies, IB, VC, hedge funds.Brand Identity, Marketing Strategy, Marketing & AGM Video, LinkedIn Strategy & Execution, Web Design & Development, CRM Support & more400+ videos100+ projects#1 content creator on LinkedIn in the lower middle market

Inherited retinal diseases can profoundly affect a child's vision and development, yet there are no approved drug treatments for most of these conditions in children. In this episode of Eye on Innovation, host Carey Powers speaks with Carmen Carrichio, CEO and founder of Raresight, about why pediatric inherited retinal diseases have historically received less attention and investment than adult diseases — and how advances in genetic testing and clinical assessment are beginning to change that.In this episode, learn about: Why treatments developed for adults cannot simply be applied to childrenWhere gene therapy may fit into the future of careRaresight's approach to developing treatments designed to remain in the eye longerHow these treatments will change the trajectory of a child's life RESOURCES: Carey Powers: Carey Powers, MBA | Ophthalmology Innovation Source  

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

Will artificial intelligence make statisticians obsolete—or make our expertise even more valuable? In this episode, I speak with independent statistical consultant Chris Harbron about how AI could reshape the role of statisticians in the pharmaceutical industry. Our conversation builds on Chris's paper, Will the Pharmaceutical Industry Need Statisticians in an AI World? We explore what happens when AI generates protocols, statistical analysis plans, programs, and reports. We also discuss why producing a plausible document differs from making sound decisions about clinical development. Chris and I examine the areas where human statisticians continue to add essential value—from navigating trade-offs and challenging assumptions to building trust and accepting accountability. We also share practical ways statisticians can begin working with AI while protecting quality, scientific rigor, and authenticity.

Mark is joined by Jonathan Dickinson, global Ibogaine expert, CEO and co-founder of Ambio Life Sciences, and author of Ibogaine and the Bicameral Mind, to discuss the therapeutic potential and clinical applications of Ibogaine. Jonathan shares insights on how Ibogaine interacts with the brain to mitigate opioid withdrawal symptoms, promote neuroplasticity, and assist in treating PTSD and traumatic brain injuries—particularly among military veterans. The two also explore ongoing clinical trials, international safety protocols, and rising legislative and federal interest in expanding research into psychedelic-assisted therapies.

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

What if the future of brain tumor treatment is closer than we think? On this episode of Game On Glio, we sit down with Dr. Annick Desjardins, neuro-oncologist and Director of Clinical Research at Duke's Preston Robert Tisch Brain Tumor Center, for a powerful conversation about where brain tumor research and treatment are headed—and what that could mean for patients and families facing a diagnosis. Dr. Desjardins takes us beyond the medical jargon and into the rapidly evolving world of brain tumor care, sharing insight into emerging treatments-including oncolytic and infection driven treatments, and clinical research. We also talk about the importance of hope, innovation, and continuing to push the boundaries of what's possible when it comes to treating brain tumors. Find brain cancer clinical trials on our website episode bio page.   Listen to this episode here, on Apple, Spotify, iHeart, or watch on our YouTube channel.   Season sponsors: GammaTile Therapy (gammatile.com)   Curtana Pharmaceuticals (curtanapharma.com)

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

In this episode, Bright and Anousha chat with Fiona Borondy-Jenkins, Program Coordinator, and Shreya Koirala, Program Manager, at the Hepatitis B Foundation about their new paper, Boosting Diverse Communities' Participation in Clinical Trials: What People Living with Hepatitis B Must Know. Together, they discuss the importance of representation in clinical research, barriers that may prevent people from participating in clinical trials, and practical information to help individuals living with hepatitis B make informed decisions about research opportunities.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

This week, we are so excited to share the third episode of our Career Development Series episodes, developed in partnership with The American Society of Hematology, The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidance to help navigate their careers. We are so excited to be partnering with an amazing organization like ASH to help make this happen!This week, we interview Hanny Al-Samkari, MD as he shares his insights on what constitutes clinical research, what a career in clinical research might look like, and how trainees can get involved in clinical research. ** This episode is created in partnership with The American Society of Hematology (https://www.hematology.org/), The ASH Trainee Council (https://www.hematology.org/education/trainees/fellows/trainee-council), and Hematopoiesis (https://www.hematology.org/education/trainees/fellows/hematopoiesis) ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Youtube

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

Joel's report: https://lnkd.in/p/epQNE9XmJPM's report: https://www.jpmorgan.com/insights/markets-and-economy/outlook/biopharma-medtech-deal-reportsMy Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

What is a nurse scientist, and what is the difference between one that is PhD-prepared versus DNP-prepared? Guest Dawn Aycock, PhD, RN, ANP-BC, FAHA, FPCNA, FAAN, shares about the importance of nurse engagement in research, and how to get involved, no matter your role or location.Related PCNA Resources:Presenting Your Work: Call for Abstracts: https://pcna.net/events-news/cardiovascular-nursing-symposium/call-for-abstracts/Empowering CV Nurses to Engage in Clinical Research (article): https://pcna.net/news/empowering-cardiovascular-nurses-to-engage-in-clinical-research/Clinical Research: Engaging with the Community (podcast): https://pcna.net/podcast/clinical-research-engaging-with-the-community/About Research and Evidence-Based Practice (article): https://pcna.net/health-topics/research-and-evidence-based-practice/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Our guest for this episode is Dr. Dallas Ehrmantraut. He is a board-certified orthopedic physical therapist, assistant professor in the University of Jamestown Physical Therapy Program, and Director of the university's Pro Bono Clinic. Residency-trained in orthopedics, Dallas also holds a Ph.D. in Clinical Research, bringing together clinical expertise, research, teaching, and a genuine passion for helping people move and perform at their best.Beyond his academic and clinical work, Dallas is an entrepreneur and advocate for accessible, high-quality physical therapy. He co-founded Forward Physical Therapy in the Fargo-Moorhead area with Bremen Abuhl, creating a practice focused on helping individuals take an active role in their recovery and long-term health.Dallas is also deeply involved in basketball. He founded Mid Minnesota Basketball and continues to serve as a club coach, giving him a unique perspective on the relationship between physical health, athletic performance, coaching, and developing young athletes.Outside of his professional pursuits, Dallas and his wife, Carrie, reside in Fargo with their children. Their family is actively involved in their church and local community. You can learn more about Dr. Ehrmantraut here: https://ptfwd.com/team/

Dr. LoVecchio joined Gaydos and Gayle Bass to share his expertise on the supplement kratom, also known as gas station heroine.

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

In today's episode, we spoke with Jonathan Trent, MD, PhD, a professor in the Department of Medicine in the Division of Medical Oncology, associate director of Clinical Research, and the director of the Sarcoma Medical Research Program at the University of Miami Miller School of Medicine in Florida.In our exclusive interview, Dr Trent discussed currently approved TKIs for patients with gastrointestinal stromal tumor (GIST), including imatinib (Gleevec), sunitinib (Sutent), regorafenib (Stivarga), and ripretinib (Qinlock). Trent dove into how these TKIs have improved outcomes for patients and touched on common adverse effects seen with these therapies, as well as how to manage these toxicities and maintain treatment adherence among patients. He also looked to liquid formulations of TKIs that are in development and the benefits they would bring to GIST management. 

Ian Hennessey, Vice President & General Counsel at CTI, joins Moving Medicine Forward to discuss the critical role legal affairs plays in advancing global clinical research. From navigating complex regulations and supporting trial operations to evaluating emerging technologies like AI, Ian shares how legal teams help organizations innovate responsibly while protecting patients and empowering scientific progress00:00 | Career Journey From healthcare law to clinical research. 02:41 | Leadership & Mentorship Building teams through trust, support, and shared problem-solving.  04:11 | Global Research Challenges Navigating regulations across countries while advancing clinical trials. 05:38 | Legal Affairs at CTI How legal operations, contracting, and compliance support research success. 07:31 | Enabling Innovation Balancing business goals, risk, and compliance with a solutions-first mindset. 08:50 | Adapting to Change Managing evolving regulations, technology, and industry expectations. 12:23 | AI and Clinical Research Exploring the opportunities and risks of emerging technologies. 15:41 | Looking Ahead Why the future of clinical research remains so promising.  17:31 | Career Advice Guidance for professionals considering a career in life sciences legal affairs.

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

Tonight on America At Night with McGraw Milhaven, David Katz, founder and principal of Katz & Associates, breaks down the political standoff surrounding Todd Blanche's nomination, examining the latest developments on Capitol Hill and what the outcome could mean for the administration and the Senate. Then, Dr. Michael Benatar, Chief of the Neuromuscular Division and Vice Chair of Clinical Research at the University of Miami Miller School of Medicine, discusses promising new research exploring whether blood tests may one day help predict ALS before symptoms appear, and what these findings could mean for earlier diagnosis, treatment and the future of ALS research. Plus, editor and author Luke Barr shares the fascinating story behind his book, The Secret History of French Cooking, exploring the people, traditions and untold history that helped shape one of the world's most celebrated cuisines. And entertainment guru Mathew Wolfe returns to break down the summer box office, discussing the biggest films, surprise hits and what audiences are watching as the summer movie season continues. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, we are exploring innovative research methodologies in genetics, including narrative and visual methods, conversation analysis and body mapping. Our guests highlight using these methods to drive inclusive and diverse research as well as providing a more nuanced understanding of the lived experiences of families.    Segment 1: Defining joy after a genetic diagnosis: A narrative inquiry   Guest Bio: UNC Greensboro Genetic Counseling Program graduate Jordan Miller earned a masters degree in genetic counseling in 2025 and currently works as a prenatal and cancer genetic counselor at Prisma Health in Columbia, South Carolina. In addition to clinical practice, Jordan serves as part of the faculty for the University of South Carolina Genetic Counseling program, where she is passionate about supporting and mentoring future genetic counselors.   Following a personal experience of finding joy after a devastating family diagnosis, Jordan developed a deep passion for exploring how joy, hope, and humanity can remain central to patient care. Her work and advocacy focus on fostering meaningful conversations about compassionate care and the ways healthcare professionals can help patients and families find moments of connection and resilience during difficult experiences.   In this segment we discuss: - The use of qualitative narrative inquiry and in-person observations, rather than standard surveys, to capture the visceral, underreported experience of joy following a family genetic diagnosis. - The "FERN" grounded framework (Focusing on the present, Embracing life, Redefining joy, and Normalizing the journey) and how its core themes emerged from family narratives. - How healthcare providers and communities can foster joy and humanize care by interacting with pediatric patients as individuals rather than focusing solely on their diagnosis. - Balancing grief and joy in healthcare conversations without pushing toxic positivity, highlighting how small daily moments of joy help families hold onto hope.   Segment 2: Expanding the methodological repertoire: Integrating multimodal approaches in genetic counseling research   Guest Bios: Ms Malebo Malope is a clinical genetic counsellor and currently employed at Stellenbosch University as a lecturer. She coordinates the teaching activities for the Clinical Genetics and Genetic Counselling Unit and leads short courses within the unit. Additionally, Malebo provides clinical genetic counselling at Tygerberg Hospital and participates in clinical training.  Ms Malope has a special interest in decision-making on termination of pregnancy for foetal abnormalities, accessible genetic counselling services and diversity and inclusion within the field of genetics and genomics.   Dr Megan Scott is a South African clinical genetic counsellor and health communication researcher based in Johannesburg. She holds a PhD in Health Communication and works in independent clinical practice, supporting individuals and families across a wide range of genetic indications, including prenatal, paediatric, oncology, ophthalmology and psychiatric genetics. She is actively involved in the South African medical genetics community, including student supervision and training and has previously served on the Genetic Counsellors South Africa (GCSA) committee. Dr Scott is also a Research Associate at the Health Communication Research Unit (HCRU) at the University of the Witwatersrand. Her research focuses on improving healthcare practice across interdisciplinary fields, qualitative research methods, risk and uncertainty discussions, family communication and patient-centred care. She has presented at local and international conferences, published in the fields of genetic counselling and health communication and regularly reviews for academic journals. She also serves as a supervisor, reviewer and examiner for postgraduate students in genetic counselling, public health, psychology and clinical medicine.   Dr Lorraine Cowley is a clinical academic with a background in oncology nursing and currently serves as Principal Genetic Counsellor at the Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust. She is also an Honorary Senior Lecturer at Newcastle University. With over 25 years of experience in patient perspectives research, Lorraine has led, co-led, supervised and contributed to numerous national and international studies, with a particular focus on improving patient-centred approaches in genetic and rare disease services. She is currently funded by the Medical Research Council (MRC) and the National Institute for Health and Social Care Research (NIHR) through a Clinical Academic Research Partnership (CARP) Fellowship. Her current work involves collaboration across Latin America and the UK to evaluate the delivery and impact of whole exome sequencing for individuals with rare muscle disorders, aiming to improve equitable access to genomic diagnostics in rare disease care.   In this segment we discuss: - How visual methods like photographic elicitation and social mapping challenge traditional biological pedigrees, revealing diverse family dynamics, gendered support roles, and moral tensions around genetic testing. - The therapeutic and harm-reduction benefits of body mapping in complex pregnancy cases, allowing patients to express embodied emotional experiences beyond verbal language. - Applying conversation analysis to real-time clinical consultations to observe non-verbal cues and explore the complex tension between counselor neutrality and institutional expectations. - The potential of multimodal methodologies to capture culturally specific kinship structures globally and their application as reflective tools in genetic counseling supervision and training.   Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Vanaja Chaava.

Natalie Crawford, MD is double board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility and author of the bestselling book, The Fertility Formula. She is co-founder of Fora Fertility, a boutique fertility practice in Austin, Texas and CEO and co-founder of Learn at Pinnacle, a medical education network. Dr. Crawford completed her undergraduate at Auburn University obtaining a degree in Nutrition Science, Medical School at University of Texas Medical Branch, OBGYN Residency at University of Texas Southwestern, and REI Fellowship at University of North Carolina, concurrently obtaining a Master of Science in Clinical Research. Today on the show we discuss how cannabis and alcohol affect fertility in men and women, how long reproductive health may take to recover after quitting, the surprising relationship between GLP 1 medications and fertility, how chronic stress and insulin resistance can make it harder to conceive, the five lifestyle habits that support healthier eggs and sperm, and why proactive fertility testing can help couples avoid losing valuable time. Try Momentous Signature Spec Creatine: https://www.livemomentous.com Use code ADVERSITY for up to 35% off your entire first order Learn more about your ad choices. Visit megaphone.fm/adchoices

Cancer treatments have changed dramatically over the past decade, but have our dose-finding strategies kept pace? In this episode, I speak with Dr. Ayon Mukherjee, who leads statistical innovation in early oncology development at Eli Lilly. Together, we explore Project Optimus, the FDA initiative that is changing how we think about dose optimization in oncology. Instead of simply finding the highest dose patients can tolerate, Project Optimus encourages us to identify the dose that provides the best balance between efficacy, safety, pharmacokinetics, pharmacodynamics, and long-term tolerability. Ayon explains why the traditional maximum tolerated dose approach worked well for chemotherapy but often falls short for targeted therapies and immunotherapies. We also discuss how statisticians can help lead this transformation by designing better dose optimization studies and collaborating more effectively with clinicians, pharmacologists, and regulators.

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

In this episode of Hema Now, Jorge Cortes reflects on the remarkable evolution of leukaemia treatment throughout his career, from the transformation of chronic myeloid leukaemia outcomes through targeted therapies to the rapidly changing landscape of acute myeloid leukaemia. He discusses the growing importance of biomarkers and patient-reported outcomes, the value of international collaboration, and how precision medicine is reshaping clinical research. Looking ahead, Cortes shares the developments in immunotherapy and personalised care that he believes could define the next era of leukaemia treatment. Timestamps:   00:00 – Introduction   01:01 – Inspiration for Haematology and Leukaemia  02:40 – Transforming Chronic Myeloid Leukaemia Care  04:55 – Future Challenges in CML  07:21 – Evolution of AML Treatment  09:50 – Biomarkers and Personalised Leukaemia Care  11:45 – Balancing Outcomes and Quality of Life  14:02 – International Collaboration in CML  16:33 – The Future of Clinical Research  20:03 – Building a Haematology Academic Career  22:04 – Exciting Advances in Leukaemia Research

Hi guys! Today's episode is super duper long and I truly have stopped caring, there's so much corruption in this world and it deserves to be covered. What corruption are we going over this week? Glad you asked! This is a continuation on our deep-dive into WHY women were actually banned from clinical research in 1977. It is absolutely crucial we understand who is behind this as *ahem* women matter and it's also Disability Pride Month! Thank you all for taking the time to listen or at least check out the resources (scroll down for the databases) - if any sources are missing it's because Youtube and podcast sites usually have a 5K letter limit. I'm using those letters explaining this - but if you need to find something, write down the key words I used and type them into ToxicDocs. By the way, NO, this is not sponsored by ToxicDocs as that's not how research databases roll. I'm just a fan. I appreciate you all! Thank you again for listening. Books: Sweet and Deadly: How Coca-Cola Spreads Disinformation and Makes Us Sick - Murray Carpenter Seed Money: Monsants's Past and Our Food Future - Barrow J. Elmore Unsavory Truth: How Food Companies Skew the Science of What We Eat - Marion Nestle  Books for Disability Pride: Against Technoableism: Rethinking Who Needs Improvement - Ashley Shew Disability Pride: Dispatches From a Post-ADA World - Ben Mattlin All Tangled Up in Autism and Chronic Illness: A Guide to Navigating Multiple Conditions - Charli Clement Sources: Summary of the Toxic Substances Control Act - 1976 https://www.epa.gov/laws-regulations/summary-toxic-substances-control-act  Superfund Amendment And Reauthorization Act of 1986 https://www.safeopedia.com/definition/9779/the-superfund-amendment-and-reauthorization-act-of-1986-sara AIM Packaging, Inc. - Sept. 6, 1977 https://cdn.toxicdocs.org/ga/gaGeEo51Z9VojeXodBNRpJEGQ/gaGeEo51Z9VojeXodBNRpJEGQ.pdf August 10, 1976 - Female Employment in Restricted Areas https://cdn.toxicdocs.org/yr/yrVo4zNGqz6Gn35jMvyne1Qa2/yrVo4zNGqz6Gn35jMvyne1Qa2.pdf Donald Kennedy and Department of Naval Research & Monsanto https://en.wikibooks.org/wiki/Professionalism/Stanford_Research_Scandal Declassified document between Navy and Monsanto: https://apps.dtic.mil/sti/pdfs/AD0837462.pdf Carter's Great Purge (July 29, 1979) https://time.com/archive/6881566/carters-great-purge/ Carter, in Angry Exchange, Ousts Bella Abzug From Women's Unit https://www.nytimes.com/1979/01/13/archives/carter-in-angry-exchange-ousts-bella-abzug-from-womens-unit.html?eafs_enabled=false  The Big Businessmen Who Have Jimmy Carter's Ear https://www.nytimes.com/1978/02/05/archives/the-big-businessmen-who-have-jimmy-carters-ear-carter.html Monsanto - Report by PCB Study Group Dec. 10, 1975 (Discussion of Brand Pivot) https://cdn.toxicdocs.org/Rj/Rjz55o2VvobRJyRKL5JzZ077V/Rjz55o2VvobRJyRKL5JzZ077V.pdf Timeline of Monsanto - https://en.wikipedia.org/wiki/Timeline_of_Monsanto Reproductive Hazards in the workplace https://cdn.toxicdocs.org/GK/GKoeDy2kzLezwkNO7XQ61BmNV/GKoeDy2kzLezwkNO7XQ61BmNV.pdf Erectile Dysfunction: A Review of Historical Treatments  https://pmc.ncbi.nlm.nih.gov/articles/PMC5675239/ Somatization Disorder Symptoms https://neupsykey.com/somatization-disorder-and-related-disorders/  Somatization Disorder (300.81) – DSM 4 https://courses.lumenlearning.com/atd-herkimer-abnormalpsych/chapter/somatization-disorder-300-81/  Environmental Erectile Dysfunction: Can the Environment Really Be Hazardous to Your Erectile Health? https://onlinelibrary.wiley.com/doi/full/10.2164/jandrol.107.004200#b23  Timeline: History of Endocrine Disrupting Chemicals https://heeds.org/heeds-timeline/ Databases Mentioned: Comparative Toxicogenomics Database https://ctdbase.org/ DEDuCT: Database of Endocrine Disrupting Chemicals and their Toxicity Profiles https://cb.imsc.res.in/deduct/home UCSF - University of California San Francisco - Industry Documents Library https://www.industrydocuments.ucsf.edu/home/ Physicians for Social Responsibility  https://psr.org/ Science Action Network for Health and the Environment https://prhe.ucsf.edu/science-action-network Open Textbook Library  https://open.umn.edu/opentextbooks/ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Julie Wendt, MS, LDN, CNS, adjunct instructor, Integrative Medicine Programs, Department of Clinical Research and Leadership, GW School of Medicine & Health Sciences, recently gave a talk on staying hydrated as the temps and humidity rise to summertime highs. As Licensed Dietician Nutritionist (LDN), Julie is a highly trained food and nutrition expert. LDNs and Registered Dietitian Nutritionists (RDN) are the only credentialed professionals legally qualified to provide medical nutrition therapy, assess nutritional needs, and build specialized meal plans for specific medical conditions. She is a LDN is Maryland, a Licensed Nutritionist in D.C., and a Certified Nutrition Specialist (CNS). Julie earned a Masters of Science in Integrative Health and Nutrition from Maryland University of Integrative Health. ◘ Related Links Julie Wendt Nutrition www.juliewendtnutrition.com Julie's Hydration Checklist https://bit.ly/4w0xx00 ◘ Transcript bit.ly/3JoA2mz ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

My Free tools for sites and researchers: https://coordinare.co/Free EDC Tool: https://crc-edc-sandbox.netlify.app/My substack FREE: https://substack.com/@dansfera1?r=27gh4e&utm_medium=ios&utm_source=profileInato: https://go.inato.com/3VnSro6CRIO: http://www.clinicalresearch.ioMy PatientACE recruitment company: https://patientace.com/Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRC Academy: http://www.TheCRCacademy.comMy TikTok: DanSfera

You've got a bottle of extra virgin olive oil sitting in your kitchen right now. I'd bet money on it.But I'd also bet you're only using it for one thing, cooking. Maybe the occasional salad dressing if you're feeling fancy. What if I told you that's like buying a Swiss Army knife and only ever using it to open envelopes?In this episode, I'm sharing eight science-backed ways olive oil can transform your health, and none of them involve a salad. We're talking about your brain, your joints, your gut, your skin, your ears, and even your snoring. Yes, really.This golden liquid has been used medicinally for thousands of years, and modern research is finally catching up to what the ancients already knew. By the end of this episode, you're going to look at that bottle on your counter completely differently.On this episode, you'll learn: How you can transform your oral health by doing THIS surprising hack (01:44)Why snoring can be your body signaling a much deeper issue (03:03)The skin secret Cleopatra and Sophia Loren both swore by (04:20)The incredible study that resulted in MRI-confirmed brain changes, improved memory, attention span, and executive function (05:34)The one mistake most people are making when it comes to their ear health (07:51)Which household item outperformed a prescription pain gel (08:45)The virtually free morning ritual that can kickstart digestion and support a healthy bowel rhythm (09:59)Why what you see on your scalp is really a sign of systemic inflammation (11:06)Three things to look for on an olive oil label before you buy (12:21)For full show notes and transcript: https://drgundry.com/olive-oil-health-benefits-science-backedThank you to our sponsors! Check them out: Get $20 off your first box plus a free year of protein, like sirloin or ribeye at ButcherBox.com/GUNDRY.Go to timelinenutrition.com/GUNDRY to get 10% off any Timeline Nutrition product.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Most clinical research treats patients like data points. What gets lost when researchers stop listening to the people they study, and what does it cost the science itself? Niharika Singh is a biomedical engineer and pre-medical student with research experience at Genentech, Abbott, AstraZeneca, and the Keck School of Medicine, and a global ambassador with the United Nations SURGhub. She discusses the KevinMD article "Patient involvement transforms modern clinical research." You will hear the difference between treating a patient as a data set, engaging them as a collaborator, and inviting their emotional and lived experience into the study design. She walks through the Tiger Project hernia training across India and Ghana, what medical device design verification taught her about surgical research, and why AI in medicine is making patient voice harder to hear. You will hear a research methodology that treats the patient's voice as data worth collecting, and a case for defending human connection as AI changes how medicine is practiced. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this episode of ACRO's GCP, Tinaya Gray (Executive Director, Site Engagement & PACE at ICON plc), Jan Hewett (SVP, FDA Regulatory Advisor at Advarra), and Jackie Kent (Independent Advisor) unpack the work of ACRO's dive team on representative, generalizable clinical trial data at the 2025 Innovation Network Gathering. Together, they explore why clinical trial populations still fail to reflect real-world patients, and what's been holding the industry back from meaningful progress.The conversation goes beyond identifying the problem. The group shares how a diverse set of stakeholders were able to align around practical, implementable solutions. They also discuss how industry can pilot new approaches, engage broader stakeholders, and turn promising ideas into standard practice. This episode offers a candid and solutions-oriented look at how to generate clinical data that truly supports better decision-making for all patients.

In this episode of the Gladden Longevity Podcast, Dr. Gladden and Leslie Kenny delve into the intricacies of aging, health, and the role of spermidine in promoting longevity. They discuss the hallmarks of aging, Leslie's personal journey with autoimmune conditions, and the importance of empowerment and curiosity in health management. The conversation emphasizes the interconnectedness of health factors and the need for a holistic approach to wellness. In this conversation, Leslie Kenny and Dr. Gladden explore the potential of spermidine as a breakthrough in aging research, discussing its effects on health, longevity, and cellular processes like autophagy. They share personal experiences with spermidine, the challenges of clinical research, and the importance of redefining aging. The conversation also highlights resources for healthy aging and the significance of mindset in health management.   For Audience Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now   Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!    Takeaways ·       Spermidine positively impacts multiple hallmarks of aging. ·       Crosstalk between hallmarks of aging can enhance health. ·       Mindset plays a crucial role in health outcomes. ·       Patients should collaborate with their healthcare providers. ·       Curiosity in medicine leads to better patient outcomes. ·       The healthcare system often lacks time for curiosity. ·       Empowerment in health management is essential. ·       Modulating the immune system can restore balance. ·       Personal experiences can lead to significant health insights. ·       Holistic approaches to health can yield better results. Spermidine activates autophagy, aiding in cellular renewal. ·       Chronic management of illnesses is not desirable; patients want solutions. ·       Biological age can be significantly lower than chronological age. ·       Spermidine has potential benefits for heart health and cognition. ·       Personal experiences with spermidine show promising results in sleep quality. ·       Clinical trials for food-derived compounds face financial challenges. ·       The body can adapt and respond positively to the right inputs. ·       Redefining aging is crucial for a healthier future. ·       Mindset plays a vital role in health and aging. ·       Resources like Oxford Health Span can provide valuable information.       Chapters 00:00 Introduction to Longevity and Health 05:23 The Role of Spermidine in Aging 08:52 Personal Journey with Autoimmune Conditions 12:34 Empowerment in Health Management 18:07 The Importance of Curiosity in Medicine 25:21 Finding Balance in Immune Health 31:32 The Quest for Longevity and Health 34:58 Spermidine: A Breakthrough in Aging Research 39:14 Personal Experience with Spermidine 44:40 Challenges in Clinical Research 49:52 Redefining Aging and Health 52:52 Resources for Healthy Aging   To learn more about Leslie Kenny: Instagram: https://www.instagram.com/lesliesnewprime/ Website: oxfordhealthspan.com, lesliesnewprime.com   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw       Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

Dr. Matthew Ithurburn, Director of Clinical Research at the American Sports Medicine Institute (ASMI) in Birmingham, Alabama, joins us to talk about the research shaping the future of sports medicine. Dr. Ithurburn leads ASMI's clinical research team, working alongside Andrews Sports Medicine and Orthopaedic Center on outcomes studies, longitudinal research, and surgical and biologic clinical trials. We dig into what this research means for athletic trainers on the ground, how it's translating into better outcomes for athletes, and where the next breakthroughs in injury prevention and recovery might come from.For more information about PBATS and athletic training, visit pbats.com. 

David Stamler, M.D., Chief Executive Officer AlterityTherapeuticsAlterity Therapeutics (NASDAQ: ATHE & ASX: ATH)www.alteritytx.com  David Stamler, M.D., Chief Executive OfficerDavid Stamler, M.D. is Chief Executive Officer and a Managing Director, and previously served as Alterity's Chief Medical Officer and Senior Vice President, Clinical Development. Dr Stamler has extensive drug development expertise spanning early-stage research through late-stage clinical trials, with three FDA drug approvals in neurology.Prior to joining Alterity, Dr. Stamler served as the Vice President, Clinical Development and Therapeutic Head for Movement Disorders at Teva Pharmaceutical Industries after Teva acquired Auspex Pharmaceuticals where he was Chief Medical Officer.Prior to Auspex, he served as Senior Vice President and Chief Medical Officer at XenoPort, Inc., and Head of Drug Development at Prestwick Pharmaceuticals, Inc. Before Prestwick, Dr. Stamler worked at Fujisawa Pharmaceutical Co. and its subsidiaries in various leadership roles, including Vice President, Research and Development, Medical Sciences at Fujisawa Healthcare, Inc., and as Vice President, Clinical Research Center at Fujisawa Research Institute of America. Dr. Stamler began his career at Abbott Laboratories where he served in various positions including Director of Clinical Research, Pharmaceutical Products for the International Division.Dr. Stamler received an M.D. from the University of Chicago—The Pritzker School of Medicine and a B.A. in Biology from the University of Chicago.

Artificial intelligence is reshaping clinical research, but its impact extends far beyond automation. In this episode of ACRO's Good Clinical Podcast, host Sophia McLeod is joined by Paulo Limgenco (VP, Business Operations at YPrime) and Michael Tucker (VP, Patient Experience - Commercial at Medidata) to explore how AI and digital technologies are helping the industry build more sustainable, efficient, and patient-centered clinical trials.From protocol optimization and site selection to localization and decentralized trial models, the conversation examines how AI can reduce operational burdens, minimize waste, and expand access to research opportunities for underrepresented populations. The discussion also highlights the importance of responsible AI adoption, including strong governance frameworks, data stewardship, and human oversight.Tune in for an insightful conversation on how the industry is balancing innovation and responsibility while working toward a future where clinical trials are more efficient, inclusive, and sustainable for patients, sites, sponsors, and communities worldwide.

Elevated GP - Click here to join Elevated.GP Follow @dr.melissa_seibert on Instagram Dr. Peter Milgrom is Professor of Oral Health Sciences and Pediatric Dentistry in the School of Dentistry and adjunct Professor of Health Services in the School of Public Health at the University of Washington. He directs the Northwest Center to Reduce Oral Health Disparities. He holds academic appointments at Case Western University, University of Rochester, and University of California, San Francisco. He maintains a dental practice limited to the care of fearful patients and served as Director of the UW Dental Fears Research Clinic. Dr. Milgrom's work includes research on xylitol, the effectiveness of fluoride varnish and iodine in preschoolers, clinical efficacy and safety of diammine silver fluoride, motivational strategies to increase perinatal and well child dental visits in rural communities, and studies of cognitive interventions in pediatric and adult dental fear. The NIH, Maternal and Child Health Bureau, HRSA, and the Robert Wood Johnson Foundation support his work. Dr. Milgrom is author of 5 books and over 300 scientific articles. His latest book, Treating Fearful Dental Patients, was published in 2009.   Dr. Milgrom was Distinguished Dental Behavioral Scientist of the International Association for Dental Research for 1999. In 1999, and again in 2000, his work was recognized by the Giddon Award for research in the behavioral sciences in Dentistry. He received the Barrows Milk Award from IADR in 2000, recognizing his work for public health including the development of the Access to Baby and Child Dentistry (ABCD) program in Washington State. In 2003, Dr. Milgrom received a Special Commendation Award from the National Legal Aid and Defenders Association and the University of Washington Medical Center Martin Luther King, Jr. Community Service Award. In 2010, he received the Aubrey Sheiham Research Award for his work on xylitol. He serves on scientific review committees for the NIDCR, NIMHHD, NINDS, Center for Scientific Review at NIH and as a consultant to the FDA. In 2005, Dr. Milgrom was appointed the SAAD Visiting Professor of Pain and Anxiety Control at the King's College Dental Institute, University of London, UK for a six-year term. In 2008 he was awarded the degree of Doctor Honoris Causa from the University of Bergen, Norway in recognition of his work in social and behavioral dentistry. In 2012, he received the University of California, San Francisco Dental Alumni Gold Medal for his contributions to Dentistry. In 2012 he was also awarded the Norton Ross Award for Excellence in Clinical Research by the American Dental Association. In 2013, he was appointed to the Council of Scientific Affairs of the American Dental Association. In 2014, he received the Irwin M. Mandel Distinguished Mentor Award from the IADR. In 2015, he served as HMDP Expert in Dental Public Health for the Singapore Ministry of Health. Dr. Milgrom received his DDS from the University of California, San Francisco in 1972 and had a previous position at the National Academy of Sciences, Engineering, and Medicine. In the last few years, Dr. Milgrom has spoken to dental associations in Argentina, Colombia, Peru, Philippines, and USA and at major universities in USA and abroad.

At the 2025 AAHKS Annual Meeting, our hosts William B. Kurtz, MD and Matthew W. Bullock, DO sat with Matthew S. Hepinstall, MD, FAAOS and Kyle L. McCormick, MD, the 2025 Clinical Research Award winners to discuss their study “Maximizing Bearing Diameter Markedly Lowers Dislocations in Primary Total Hip Arthroplasty” that was presented at the AAHKS Annual Meeting.   Prevention of dislocation is a topic of interest for Drs. Hepinstall and McCormick which is what prompted this study that consisted of over 8,000 patients who underwent fixed-bearing THA. Because modern polyethylene allows larger bearings in fixed-bearing THA, stability benefits of fully maximizing bearing diameter (e.g. 36-mm in 48/50-mm cups) are not well established. Drs. Hepinstall and McCormick discussed on the podcast the number of dislocations in the study with patients with maximized bearing diameters and how certain variables such as age, sex and body-mass index help to protect against dislocation.  For more on how fully maximizing bearing diameter reduced dislocation odds in primary fixed-bearing THA, listen to the full podcast. Don’t forget to subscribe and thanks for listening to AAHKS Amplified! In This Episode:Matthew W. Bullock, DO Matthew S. Hepinstall, MD, FAAOSWilliam B. Kurtz, MDKyle L. McCormick, MD  The post The 2025 AAHKS Clinical Research Award Winner first appeared on AAHKS.

Theo Jaffee and Gabriel Dickinson speak with Cremieux about China's rapid rise to the top of global clinical trial output. They discuss the regulatory reforms that accelerated China's progress, the surge in novel drug development, and what the US would need to change to stay competitive in biomedical innovation.   Resources: Follow Cremieux on X: https://x.com/cremieuxrecueil Follow Theo on X: https://x.com/theojaffee Follow Gabriel on X: https://x.com/gbrl_dick   Stay Updated:Find a16z on YouTube: YouTubeFind a16z on XFind a16z on LinkedInListen to the a16z Show on SpotifyListen to the a16z Show on Apple PodcastsFollow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get My Brand Masterlist: https://drchristiangonzalez.com/best-brands-form-2-2/ → Shop all my verified, tested and preferred wellness products - includes most up to date brands: https://theswellscore.com/pages/drg Episode Description You started creatine, felt bloated, broke out, noticed your hair shedding — and then wondered if you were crazy. You weren't. But you were missing something important. Creatine is one of the most well-researched supplements in history. But almost all of that research was done on men. And when the wellness world rebranded it as a brain and energy supplement for women, nobody stopped to talk about hormones, cycle phases, gut tolerance, or the environment your body is actually in when you start taking it. Dr. G breaks down exactly what's happening — and who creatine is actually for. In this episode, you'll learn:  • Why creatine causes bloating, breakouts, and hair shedding in some women — and what it's actually telling you about your physiology  • The three groups of women when it comes to creatine: who benefits, who needs a modified approach, and who should skip it entirely for now  • What has to be in place before creatine can actually work — and why taking it on top of poor sleep, undereating, or overtraining almost always backfires If you've tried creatine and felt worse, or you're wondering if it's worth trying — this is the episode that gives you a real answer. Timestamps: 0:00 - Intro 1:00 - Why Creatine Crossed Over Into Women's Wellness (And What the Research Actually Says) 2:32 - How Creatine Actually Works in the Female Body 4:03 - What the Clinical Research on Women and Creatine Really Shows 5:28 - Bloating, Breakouts & Hair Shedding: What's Actually Causing It 7:04 - Why Your Physiology May Not Match What Creatine Is Asking of You 10:40 - The Three Groups: Who Should Take It, Who Should Be Careful, Who Should Skip It 12:33 - Final Word: Always Talk to a Professional First Learn more about your ad choices. Visit megaphone.fm/adchoices

Natalie Crawford, MD is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility and is co-founder of Fora Fertility, a boutique fertility practice in Austin, Texas. Dr. Crawford is CEO and co-founder of Pinnacle, a professional network for women in medicine. She completed her undergraduate at Auburn University obtaining a degree in Nutrition Science, Medical School at UTMB, OBGYN Residency at UTSW, and REI Fellowship at UNC, concurrently obtaining a Master of Science in Clinical Research. Dr. Crawford is a digital health educator on social media, YouTube, and hosts the podcast  “As a Woman” with over 6 million downloads. Her debut book, “The Fertility Formula”, will be released by Penguin Random House.   Follow Dr. Crawford on Instagram at @nataliecrawfordmd and check out her book, The Fertility Formula.   Related Episodes: Ep 155 - Dr. Marguerite Duane on FACTS about Fertility Ep 314 - The Fertility Crisis + Support for Couples with Ronit Menashe + Vida Delrahim   If you like this episode, please subscribe to Pursuing Health on iTunes and give it a rating or share your feedback on social media using the hashtag #PursuingHealth. I look forward to bringing you future episodes with inspiring individuals and ideas about health.   Disclaimer: This podcast is for general information only, and does not provide medical advice.  I recommend that you seek assistance from your personal physician for any health conditions or concerns.